Last reviewed · How we verify

NCT04493593

Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility

Completed NA Last updated 29 January 2021
What this trial tests

NA trial testing SilverCloud in Insomnia in 60 participants. Completed in 21 June 2020.

Timeline
5 September 2019
Primary endpoint
21 June 2020
21 June 2020

Quick facts

Lead sponsorSilver Cloud Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment60
Start date5 September 2019
Primary completion21 June 2020
Estimated completion21 June 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Silver Cloud Health

Who can join

Adults 18 to 80, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The principal objective of the study is to assess the feasibility and preliminary efficacy of an online-delivered CBT-I intervention for those with insomnia or reporting sleep difficulties. The program will be offered to service users of IAPT to establish criteria for the planning of a future large scale RCT study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Internet-delivered CBT intervention (<i>Space for Sleep</i>) for insomnia in a routine care setting: Results from an open pilot study.
    Wogan R, Enrique A, Adegoke A, Earley C, et al · · 2021 · cited 6× · PMID 34430222 · DOI 10.1016/j.invent.2021.100443

Verify or expand the search:

Other trials of SilverCloud

Trials testing the same drug.

Other recruiting trials for Insomnia

Currently open trials in the same condition.

Other Silver Cloud Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04493593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing